Warning: The NCBI web site requires JavaScript to function. more...
Serum proteomic profiling and haptoglobin polymorphisms in patients with GVHD after allogeneic hematopoietic cell transplantation.
McGuirk J, Hao G, Hou W, Abhyankar S, Williams C, Yan W, Yuan J, Guan X, Belt R, Dejarnette S, Wieman J, Yan Y.
J Hematol Oncol. 2009 Apr 20;2:17.
Related citations
Contribution of TNF-alpha and IL-10 gene polymorphisms to graft-versus-host disease following allo-hematopoietic stem cell transplantation.
Takahashi H, Furukawa T, Hashimoto S, Suzuki N, Kuroha T, Yamazaki F, Inano K, Takahashi M, Aizawa Y, Koike T.
Bone Marrow Transplant. 2000 Dec;26(12):1317-23.
Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT.
Solano C, Martinez C, Brunet S, Tomás JF, Urbano-Ispizua A, Zuazu J, Ojeda E, Bargay J, Moraleda JM, Bailen A, Sierra J, García-Conde J, Rozman C.
Bone Marrow Transplant. 1998 Dec;22(12):1129-35.
Change in serum proteome during allogeneic hematopoietic stem cell transplantation and clinical significance of serum C-reactive protein and haptoglobin.
Ryu J, Lee SR, Park SG, Kang S, Kim HJ, Park BC.
Exp Mol Med. 2010 Sep 30;42(9):651-61.
High incidence of chronic graft versus host disease after allogeneic peripheral blood progenitor cell transplantation. The Spanish Group of Allo-PBPCT.
Urbano-Ispizua A, García-Conde J, Brunet S, Hernández F, Sanz G, Petit J, Bargay J, Figuera A, Rovira M, Solano C, Ojeda E, de la Rubia J, Rozman C.
Haematologica. 1997 Nov-Dec;82(6):683-9.
Accurate diagnosis of acute graft-versus-host disease using serum proteomic pattern analysis.
Srinivasan R, Daniels J, Fusaro V, Lundqvist A, Killian JK, Geho D, Quezado M, Kleiner D, Rucker S, Espina V, Whiteley G, Liotta L, Petricoin E, Pittaluga S, Hitt B, Barrett AJ, Rosenblatt K, Childs RW.
Exp Hematol. 2006 Jun;34(6):796-801.
The effect of extracorporeal photoimmunotherapy (ECP) on serum TNF-a level in chronic graft versus host disease (GvHD).
Ayyildiz E, Arslan O, Topçuoğlu P, Arat M, Dalva K, Soydan EA, Tol M, Ilhan O.
Transfus Apher Sci. 2007 Feb;36(1):79-85. Epub 2007 Jan 17.
Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning.
Poloni A, Sartini D, Emanuelli M, Trappolini S, Mancini S, Pozzi V, Costantini B, Serrani F, Berardinelli E, Renzi E, Olivieri A, Leoni P.
Cytokine. 2011 Mar;53(3):376-83. Epub 2011 Jan 5.
IL2 and TNFA gene polymorphisms and the risk of graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
Viel DO, Tsuneto LT, Sossai CR, Lieber SR, Marques SB, Vigorito AC, Aranha FJ, de Brito Eid KA, Oliveira GB, Miranda EC, de Souza CA, Visentainer JE.
Scand J Immunol. 2007 Dec;66(6):703-10.
Molecular analysis of T-cell repertoire in patients with graft-versus-host disease after allogeneic stem cell transplantation.
Tsutsumi Y, Tanaka J, Miura Y, Toubai T, Kato N, Fujisaw F, Toyoshima N, Ota S, Mori A, Yonezumi M, Chiba K, Kondo T, Hasino S, Kobayasi R, Masauji N, Kasai M, Asaka M, Imamura M.
Leuk Lymphoma. 2004 Mar;45(3):481-8.
Association between serum high-molecular-weight adiponectin level and the severity of chronic graft-versus-host disease in allogeneic stem cell transplantation recipients.
Nakasone H, Binh PN, Yamazaki R, Tanaka Y, Sakamoto K, Ashizawa M, Sato M, Terasako K, Kimura S, Kikuchi M, Kako S, Okuda S, Oshima K, Tanihara A, Nishida J, Abe Y, Kanda Y.
Blood. 2011 Mar 24;117(12):3469-72. Epub 2011 Jan 21.
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL.
Dan Med Bull. 2007 May;54(2):112-39. Review.
NanoLC-MS/MS analyses of urinary desmosine, hydroxylysylpyridinoline and lysylpyridinoline as biomarkers for chronic graft-versus-host disease.
Boutin M, Ahmad I, Jauhiainen M, Lachapelle N, Rondeau C, Roy J, Thibault P.
Anal Chem. 2009 Nov 15;81(22):9454-61.
[Study on graft-versus-host disease in the allogeneic peripheral blood stem cell transplantation for the treatment of leukemia].
Zhang WP, Wang JM, Ju XP, Song XM, Tong SP, Li HM.
Zhonghua Xue Ye Xue Za Zhi. 2003 Mar;24(3):129-33. Chinese.
Gene expression profiling-based identification of CD28 and PI3K as new biomarkers for chronic graft-versus-host disease.
Lai P, Weng J, Lu Z, Guo R, Luo C, Wu S, Ling W, Geng S, Du X.
DNA Cell Biol. 2011 Dec;30(12):1019-25. Epub 2011 Jun 17.
Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
Kim HJ, Min WS, Cho BS, Eom KS, Kim YJ, Min CK, Lee S, Cho SG, Jin JY, Lee JW, Kim CC.
Biol Blood Marrow Transplant. 2009 Jun;15(6):704-17. Epub 2009 Apr 9.
[Clinical study on haploid HLA-matched hematopoietic stem cell transplantation for treatment of malignant hematological disease].
Sun AN, Wu DP, Wang Y, Qiu HY, Jin ZM, Miao M, Tang XW, Fu ZZ, Ma X, Han Y, He GS, Chen SN, Xue SL, Zhao Y.
Ai Zheng. 2006 Aug;25(8):1019-22. Chinese.
Serum macrophage migration inhibitory factor (MIF) levels after allogeneic hematopoietic stem cell transplantation.
Toubai T, Shono Y, Nishihira J, Ibata M, Suigita J, Kato N, Ohkawara T, Tone S, Lowler KP, Ota S, Tanaka J, Asaka M, Reddy P, Imamura M.
Int J Lab Hematol. 2009 Apr;31(2):161-8. Epub 2007 Dec 12.
Risk assessment and outcome of chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell transplantation in pediatric patients.
Diaz MA, Vicent MG, Gonzalez ME, Verdeguer A, de la Rubia J, Bargay J, de Arriba F, Diez JL, Caballero D, Madero L, Brunet S; Spanish Group for Allogeneic Peripheral Blood Transplantation.
Bone Marrow Transplant. 2004 Sep;34(5):433-8.
Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation.
Pérez-Simón JA, Díez-Campelo M, Martino R, Brunet S, Urbano A, Caballero MD, de León A, Valcárcel D, Carreras E, del Cañizo MC, López-Fidalgo J, Sierra J, San Miguel JF.
Br J Haematol. 2005 Aug;130(3):394-403.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on